Aarti Pharmalabs Limited has informed the Exchange about Schedule of meet
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aarti Pharmalabs Limited has informed stock exchanges about a scheduled investor and analyst meeting scheduled for May 28, 2026. The meeting is part of the 360 ONE Capital Conference called 'Trinity 2026' and will be held in physical mode. The company clarified this meeting is to discuss ordinary course of business matters. As required under SEBI regulations, the company explicitly stated that no unpublished price sensitive information (UPSI) will be shared during the meeting. This is a routine regulatory compliance filing under Regulation 30 of SEBI (LODR) Regulations 2015.
This is a standard investor relations activity with no material impact on stock price. The filing demonstrates the company's commitment to transparency and regular investor engagement, while the explicit UPSI disclaimer protects against any regulatory concerns.